MY ADVANCED PROSTATE CANCER JOURNEY UPDATED 7/20/2018
I was diagnosed with Stage IV Metastatic Prostate Cancer in July 2014; at the time, I was a very active and healthy 51-year-old male with no notable medical conditions. A biopsy and numerous scans confirmed prostate cancer was active in all my major bones from head to toe and I had spots in my liver, pelvis and spinal cord.
July 2014 - Stage IV Metastatic Prostate Cancer
PSA = 89.7 Alk Phosphatase = 1493
Upon my diagnoses, I immediately started a combined treatment of Leuprolide (Eligard, Lupron) hormone injection every 90-days, Bicalutamide (Casodex) 50mg tablet daily and chemotherapy Taxotere 6-rounds. To help my bone health I started a twice daily high dose of CITRACAL "CALCIUM+D and an infusion of Zometa every 90-days.
The treatment had an immediate effect on my cancer. My PSA lowered to under 1.0 and my Alk Phosphatase went down to less than 50.
September 2016 - Stage IV Castrate Resistant Metastatic Prostate Cancer (CRMPC)
PSA = 1.53 – 3.64
In early September of 2016 my PSA began to rise at this time I was informed I became immune to the hormone treatment. In other words; my cancer evolved to Castrate Resistant Metastatic Prostate Cancer. At this point my next line of defense was to start a daily dose of Xtandi (Enzalutamide). Xtandi is a hormone therapy classified as an "anti-androgen” Along with Xtandi, I also continued with my combined treatment of hormone Lupron injection every 90-days, Bicalutamide (Casodex) 50mg tablet, twice daily high dose of CITRACAL "CALCIUM+D and an infusion of Zometa every 90-days.
August 2017 - Stage IV CRMPC (Foundation ONE Genomic Biopsy)
PSA = 11.80
With my CRMPC advancing I elected to hold off on my next form of treatment to basically clear out my system and then get a biopsy sent to Foundation ONE for Genomic testing to see if my cancer altered into another form. Unfortunately, this test turned out to be a total failure because the team at AURORA MEDICAL CENTER GRAFTON did not expedite the biopsy in a timely manner (they lost the biopsy internally) nor did the pathologist prepare the biopsy per Foundation ONE’s instructions.
September 2017 - Stage IV CRMPC (Foundation ACT Genomic Blood Test)
PSA = 13.80
With the progression of my cancer I could not afford to wait and schedule another surgery to obtain a second biopsy nor could I wait for the standard two week turnaround for Foundation ONE testing so I elected to go with the quicker less informative test “Foundation ACT” blood test. This test was prepared and properly sent to Foundation Medicine, but unfortunately the test did not show any signs of genomic alterations. Results as follows….
TUMOR TYPE: PROSTATE ACINAR ADENOCARCINOMA
(0) genomic alterations Genomic Alterations Identified†
No Reportable genomic alterations were detected
No Clinical or Therapeutic Trials available
October 2017 - Stage IV CRMPC (PSA on the Rise Again)
PSA = 15.90
In May 2017 we saw my PSA on the rise again. By October 2017 my PSA was up to 15.90 so my oncologist recommended injections of Radium 223 (Dichloride, Xofigo) Between October 2017 and March 2018 I had (6) injections (1) every four weeks. I continued my daily dose of Xtandi (Enzalutamide) and my daily hormone medication Biclutamide (Casodex).
March 2018 - Stage IV CRMPC (PSA still on the Rise)
PSA = 38.90
The Radium slowed my PSA increase but did not do enough to slow my disease. By March 2018 my PSA was up to 38.90 and rising. I was told to continue with my daily dose of Xtandi (Enzalutamide) along with the hormone treatment, Lupron injection every 90-days and a twice daily high dose of CITRACAL "CALCIUM+D and an infusion of Zometa every 90-days. At this time I was told to stop taking the daily hormone medication Biclutamide (Casodex). Per my oncologist, the Biclutamide (Casodex) should have been eliminated/stopped in September 2016 when I started Xtandi (Enzalutamide). This was over-looked.
May 2018 - Stage IV CRMPC (PSA Rising Faster)
PSA = 52.90
With my PSA still on the rise 52.90, we elected to begin chemotherapy again. This time we selected Cabazitaxel (Jevtana) along with prednisone; I would get 6 to 10 infusions, one infusion every three weeks. I continued with the hormone treatment, Lupron injection every 90-days and am still taking a twice daily high dose of CITRACAL "CALCIUM+D and an infusion of Zometa every 90-days. At this time, I was told to stop taking the daily dose of Xtandi (Enzalutamide).
May 2018 - Stage IV CRMPC (Chemo Not Working)
PSA = 89.70
By June 2018 I had three infusions under my belt yet my PSA continued a steady rise and was up to 89.7. With that being said, my oncologist informed me the chemotherapy treatments of Cabazitaxel (Jevtana) are not working and we will need to start investigating precision medicine or clinical trials.